RE:RE:RE:RE:RE:I hope LABS shareholders realize we are on the cuspNDA with pharmaceutical partner and FDA masterfile is for EPIDIOLEX generic...medipharm will produce and pharmaceutical partner will distribute through existing channels.....this isn't speculative it's based on management commentary and steps taken to reach this point...NDA's are signed during negotiations...once partnership is finalized trading halt will proceed announcement...also the NDA prevents insider buying...